50 completed, 11 terminated, 9 recruiting, 9 withdrawn. 87 Phase 3, 20 Phase 2.
Follow Emory University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis Emicizumab, FEIBA, rFVIIa - Hemophilia A | Phase 3 | Recruiting | Emory University | 5 | 2026-09-01 | 2026-08-21 |
| Sleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients Standard Postoperative Care, Zolpidem, Melatonin - Orthopedic Trauma, Sleep Quality | Phase 3 | Recruiting | Emory University | 30 | 2026-06-02 | 2026-07-30 |
| Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes Semaglutide - Diabetes Mellitus, Type 2 | Phase 3 | Recruiting | Emory University | 20 | 2026-05-07 | 2026-08-03 |
| Opioid-Sparing Joint Replacement Placebo, Oxycodone 5 mg, Multimodal Non-Opioid Analgesia - Pain Management, Opioid Consumption | Phase 3 | Recruiting | Emory University | 120 | 2026-03-19 | 2026-04-17 |
| Efficacy of EXPAREL vs. Bupivacaine EXPAREL, 0.25% bupivacaine (HCl): 50 ml, 0.25% bupivacaine (HCl): 30 ml - Total Ankle Arthroplasty, Postsurgical Analgesia | Phase 3 | Recruiting | Emory University | 104 | 2025-11-17 | 2026-02-23 |
| Improving Mobility After Revascularization in Peripheral Artery Disease Home Based Exercise, Nitrate Rich Beetroot Juice, Attention Control - Peripheral Artery Disease, Intermittent Claudication | Phase 3 | Recruiting | Northwestern University | 386 | 2025-08-04 | 2026-10-05 |
| REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial Abiraterone Acetate, Bicalutamide, Biospecimen Collection - Recurrent Prostate Carcinoma, Stage III Prostate Cancer AJCC v8 | Phase 3 | Recruiting | Emory University | 72 | 2025-01-31 | 2026-02-24 |
| Automated Insulin Delivery for Inpatients With Dysglycemia AID system with Remote Real-Time CGM, Standard of Care Insulin Therapy + CGM - Type 1 Diabetes, Type 2 Diabetes | Phase 3 | Completed | Emory University | 130 | 2025-01-22 | 2025-11-14 |
| High Versus Lower Intensity Surveillance Following Resection of Retroperitoneal Sarcoma High-intensity radiological surveillance, Lower-intensity radiological surveillance - Sarcoma,Soft Tissue, Sarcoma Retroperitoneal | Phase 3 | Not yet recruiting | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 584 | 2024-11-01 | 2024-10-16 |
| REVERSE-Long COVID-19 With Baricitinib Study Baricitinib 4 MG, Placebo - Post-Acute COVID-19 Syndrome | Phase 3 | Withdrawn | Vanderbilt University Medical Center | 2024-10-21 | 2026-09-09 | |
| Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial Cetirizine, Famotidine, Cetirizine Placebo - COVID-19 | Phase 3 | Terminated | Emory University | 5 | 2024-03-08 | 2025-07-17 |
| Function of Tamsulosin in Older Males Undergoing Surgery With Indwelling Catheter Tamsulosin, Control Group - Postoperative Urinary Tract Infection | Phase 3 | Completed | Emory University | 87 | 2024-02-26 | 2026-04-09 |
| Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3 Transcutaneous Cervical Vagal Nerve Stimulation, Sham Stimulation, [F-18]Fallypride - Withdrawal Symptoms, Opioid Use Disorder | Phase 3 | Recruiting | Emory University | 103 | 2024-02-20 | 2026-03-27 |
| Add-on Dupilumab for AFRS as Postoperative Therapy (ADAPT) Dupilumab, Placebo, Intranasal Corticosteroid Sprays (INCS) - Allergic Fungal Rhinosinusitis | Phase 3 | Terminated | Emory University | 5 | 2023-10-26 | 2025-05-08 |
| Oral N-acetylcysteine for Retinitis Pigmentosa N-acetylcysteine, Placebo - Retinitis Pigmentosa | Phase 3 | Active not recruiting | Johns Hopkins University | 485 | 2023-10-11 | 2026-06-15 |
| Integration of HPV Vaccination and HPV-based Cervical Screening Into ARV Clinics: the H2VICTORY Trial HPV vaccine, HPV testing, HAV vaccine - HPV Infection | Phase 3 | Not yet recruiting | International Agency for Research on Cancer | 8000 | 2023-02-01 | 2022-08-03 |
| Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine NmCV-5, MenACWY-TT - Meningitis | Phase 3 | Completed | Emory University | 1325 | 2022-03-24 | 2026-03-31 |
| Emicizumab PUPs and Nuwiq ITI Study Nuwiq (low dose protocol), HEMLIBRA, Nuwiq (Atlanta protocol) - Hemophilia A | Phase 3 | Withdrawn | Emory University | 2022-02-17 | 2024-01-05 | |
| AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department Azithromycin, Placebo - Asthma, Wheezing | Phase 3 | Terminated | University of Arizona | 840 | 2021-11-22 | 2026-06-23 |
| Metformin in Alzheimer's Dementia Prevention Placebo oral tablet, extended release metformin - Mild Cognitive Impairment | Phase 2 / Phase 3 | Active not recruiting | Columbia University | 326 | 2021-03-22 | 2026-08-11 |
Showing 20 of 87. Sign in to see all of them.
Diabetes Mellitus (7) · Inflammation (5) · Agnosia (3) · COVID-19 (3) · Diabetes Mellitus, Type 2 (3) · Insulin Resistance (3) · Stress Disorders, Post-Traumatic (3) · Coronary Artery Disease (2) · Cystic Fibrosis (2) · Depressive Disorder, Major (2) · Diabetes Mellitus, Type 1 (2) · HIV Infections (2) · Hemophilia A (2) · Hypertension (2) · Influenza, Human (2)
Azithromycin (3) · Radiotherapy (3) · Standard of Care (3) · ClinOleic (2) · Cycloserine (2) · Influenza Vaccines (2) · Metformin (2) · Oxycodone (2) · Practice Guidelines as Topic (2) · Radiation (2) · Saline Solution (2) · Water (2) · emicizumab (2) · soybean oil, phospholipid emulsion (2) · vaxigrip (2)
United States (72) · Canada (5) · South Africa (2) · United Kingdom (2) · Australia (1) · Austria (1) · Brazil (1) · Denmark (1) · Ethiopia (1) · Germany (1) · India (1) · Ireland (1) · Italy (1) · Mali (1) · Netherlands (1)
Catherine Meyers, M.D. (2) · Guillermo E Umpierrez, MD (2) · Guillermo Umpierrez, MD (2) · James D Bremner, MD (2) · John W Kusek, Ph.D. (2) · Keith P Klugman, MD, PhD (2) · Robert Sidonio, MD (2) · Shabir A Madhi, MD, PhD (2) · Adriana Weinberg (1) · Adriana Weinberg, PhD (1) · Ajay K Nooka (1) · Ajay Premkumar, MD (1) · Ajay Rangaraj, MD, MSc (1) · Alessandro Doria, MD, PhD, MPH (1) · Andrew G Herzog, M.D., M.Sc. (1)
PMID 18477783, PMID 25184864, PMID 28369198, PMID 29253090, PMID 35224730, PMID 38743692, PMID 39513526, PMID 15349872, PMID 18779478, PMID 19458364, PMID 20008945, PMID 20946227, PMID 21832112, PMID 22449224, PMID 22488002, PMID 23236082, PMID 23517449, PMID 23945571, PMID 24743802, PMID 25155070, PMID 25272149, PMID 25365551, PMID 25802980, PMID 25842051, PMID 26501700, PMID 26890209, PMID 27183343, PMID 27380464, PMID 27988146, PMID 28327462, PMID 28575286, PMID 28994661, PMID 29111077, PMID 30059794, PMID 30172724, PMID 30793177, PMID 30953543, PMID 31669451, PMID 31801567, PMID 32007132, PMID 32317004, PMID 32404437, PMID 32579810, PMID 32868130, PMID 32960179, PMID 33344717, PMID 33619183, PMID 33620405, PMID 33664081, PMID 33971152
P30CA138292 (3), R01MH070437 (2), U01DK058982 (2), 1UG1EY033293 (1), 4UH3DA048502 (1), K12AR084234 (1), R01AG062624 (1), R01CA169188 (1), R01DK138366 (1), R01HD096559 (1), R01MH070880 (1), U01DK069322 (1), U10EY023939 (1), UC4DK101108-01 (1), UG3DA048502 (1)